Taigen Biopharmaceuticals Holdings Ltd (4157) — Strategic Asset Allocation Index
Taigen Biopharmaceuticals Holdings Ltd (4157) has a Strategic Asset Allocation Index of 10.7% as of June 2023. Strategic assets (PP&E of NT$102.01 Million plus long-term investments of NT$-) total NT$102.01 Million, measured against net assets of NT$952.23 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check asset resilience ratio of Taigen Biopharmaceuticals Holdings Ltd to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Taigen Biopharmaceuticals Holdings Ltd Strategic Asset Allocation Index (2011–2022)
This chart shows how Taigen Biopharmaceuticals Holdings Ltd's Strategic Asset Allocation Index has evolved across 12 annual periods from 2011 to 2022. As of June 2023, the index stands at 10.7%, representing strategic assets of NT$102.01 Million against net assets of NT$952.23 Million TWD. See 4157 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Taigen Biopharmaceuticals Holdings Ltd (2011–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Taigen Biopharmaceuticals Holdings Ltd from 2011 to 2022, covering 12 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 4157 market cap.
| Year | SAAI | Strategic Assets (TWD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 5.8% | NT$56.60 Million | NT$56.60 Million | NT$- | NT$970.03 Million | ▼ -0.6 pp |
| 2021 | 6.4% | NT$80.43 Million | NT$80.43 Million | NT$- | NT$1.25 Billion | ▼ -3.2 pp |
| 2020 | 9.6% | NT$42.47 Million | NT$42.47 Million | NT$- | NT$442.18 Million | ▼ -14.8 pp |
| 2019 | 24.4% | NT$198.65 Million | NT$64.83 Million | NT$133.82 Million | NT$815.18 Million | ▼ -4.2 pp |
| 2018 | 28.5% | NT$312.01 Million | NT$31.95 Million | NT$280.07 Million | NT$1.09 Billion | ▲ +0.7 pp |
| 2017 | 27.8% | NT$396.25 Million | NT$19.35 Million | NT$376.91 Million | NT$1.42 Billion | ▲ +26.0 pp |
| 2016 | 1.8% | NT$12.38 Million | NT$12.38 Million | NT$- | NT$675.62 Million | ▼ -0.8 pp |
| 2015 | 2.7% | NT$11.74 Million | NT$11.74 Million | NT$- | NT$441.60 Million | ▲ +1.2 pp |
| 2014 | 1.5% | NT$12.63 Million | NT$12.63 Million | NT$- | NT$852.14 Million | ▼ -7.0 pp |
| 2013 | 8.5% | NT$13.10 Million | NT$13.10 Million | NT$- | NT$153.77 Million | ▲ +5.2 pp |
| 2012 | 3.3% | NT$12.38 Million | NT$12.38 Million | NT$- | NT$372.80 Million | ▲ +0.7 pp |
| 2011 | 2.6% | NT$13.29 Million | NT$13.29 Million | NT$- | NT$513.21 Million | — |